Idogen AB (publ)

OM:IDOGEN Stock Report

Market Cap: SEK 12.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Idogen Management

Management criteria checks 1/4

Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.

Key information

Christina Herder

Chief executive officer

SEK 454.0k

Total compensation

CEO salary percentage66.08%
CEO tenureless than a year
CEO ownership0.06%
Management average tenure1.5yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Christina Herder's remuneration changed compared to Idogen's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-SEK 44m

Dec 31 2022SEK 454kSEK 300k

-SEK 48m

Sep 30 2022n/an/a

-SEK 50m

Jun 30 2022n/an/a

-SEK 41m

Mar 31 2022n/an/a

-SEK 39m

Dec 31 2021SEK 150kn/a

-SEK 39m

Sep 30 2021n/an/a

-SEK 33m

Jun 30 2021n/an/a

-SEK 33m

Mar 31 2021n/an/a

-SEK 31m

Dec 31 2020SEK 150kn/a

-SEK 27m

Compensation vs Market: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).

Compensation vs Earnings: Christina's compensation has increased whilst the company is unprofitable.

CEO

Christina Herder (62 yo)

less than a year

Tenure

SEK 454,000

Compensation

Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...

Leadership Team

NamePositionTenureCompensationOwnership
Christina Herder
Acting CEO & Directorless than a yearSEK 454.00k0.060%
SEK 7.6k
Leif Salford
Founder & Chairman of the Scientific Advisory Boardno dataSEK 150.00k0.17%
SEK 22.0k
Ingvar Karlsson
Chief Financial Officer7.2yrsno data0.33%
SEK 42.1k
Dennis Henriksen
Chief Technology Officer9.5yrsSEK 120.74k0.012%
SEK 1.5k
Hanjing Xie
Chief Medical Officer1.5yrsno datano data
Rory Graham
Chief Regulatory Officer1.3yrsno datano data

1.5yrs

Average Tenure

62yo

Average Age

Experienced Management: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Christina Herder
Acting CEO & Director6.2yrsSEK 454.00k0.060%
SEK 7.6k
Leif Salford
Founder & Chairman of the Scientific Advisory Board7.8yrsSEK 150.00k0.17%
SEK 22.0k
Agneta Edberg
Independent Chairman of the Board7.3yrsSEK 407.00k0.15%
SEK 18.9k
Rolf Ljung
Member of Scientific Advisory Board7.8yrsno datano data
Jolanda de Vries
Member of Scientific Advisory Board2.3yrsno datano data
Sharon Longhurst
Independent Director3.2yrsSEK 150.00k0.089%
SEK 11.1k
Michaela Sharpe
Member of Scientific Advisory Board2.3yrsno datano data
Bo-Goran Ericzon
Member of Scientific Advisory Board2.3yrsno datano data
Michael Uhlin
Member of Scientific Advisory Boardless than a yearno datano data
Mats Bemark
Member of Scientific Advisory Boardless than a yearno datano data

2.7yrs

Average Tenure

64.5yo

Average Age

Experienced Board: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/07/11 08:02
End of Day Share Price 2023/07/06 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Idogen AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Klas PykNordea Markets
Maria Karlsson OsipovaPenser Access
Filip EinarssonRedeye